Goldman Sachs’s CAREFUSION CORPORATION CFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-9,000
Closed -$534K 7520
2014
Q4
$534K Buy
9,000
+5,200
+137% +$299K ﹤0.01% 5220
2014
Q3
$172K Buy
3,800
+600
+19% +$27K ﹤0.01% 6279
2014
Q2
$142K Sell
3,200
-4,800
-60% -$199K ﹤0.01% 6408
2014
Q1
$322K Sell
8,000
-24,800
-76% -$1M ﹤0.01% 5686
2013
Q4
$1.31M Sell
32,800
-13,200
-29% -$513K ﹤0.01% 4498
2013
Q3
$1.7M Sell
46,000
-45,500
-50% -$1.7M ﹤0.01% 4079
2013
Q2
$3.37M Buy
+91,500
New +$3.23M ﹤0.01% 3155

Other funds holding CFN

Goldman Sachs's CFN Position: Q1 2015 in Review

Goldman Sachs sold out of CAREFUSION CORPORATION (CFN) in Q1 2015, closing a stake of 1,112,183 shares — an estimated $66M sold.

Goldman Sachs first reported a position in CFN in Q2 2013 and held it in 7 quarters. The position peaked at $311M in Q4 2013. 3 funds tracked by Wall St. Rank hold CFN as of Q1 2015.

  • Goldman Sachs reported no remaining CAREFUSION CORPORATION position as of Q1 2015 after selling out during the quarter.
  • Goldman Sachs sold 1,112,183 CAREFUSION CORPORATION shares in Q1 2015, an estimated $66M.
  • Goldman Sachs first reported a position in CAREFUSION CORPORATION in Q2 2013 and held it in 7 quarters.
  • Goldman Sachs's CAREFUSION CORPORATION position peaked at $311M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.